Tapewire

NYSE · USD

WAT

WATERS CORP /DE/

Export transactions ↓
Tapewire entity
3080
SEC CIK
0001000697
Parsed reports
560

Last 12 months

Inside the activity.

2 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2026 Filed Oct 3, 2026 01:11 UTC GrantCommon Stock 57.41 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000138 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,337.95

F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2027, pursuant to an election previously made by the Reporting Person.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 01:08 UTC
Jiang WeiDirector
GrantCommon Stock 57.41 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000136 · form4.xml · nonDerivative · entry 1

Jiang Wei · CIK 0001867980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,630.16

F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors.

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 3,626 $0.00 Strike: $136.43 $0.00
Disclosure

SEC source: 0001000697-26-000127 · form4.xml · derivative · entry 3

KUEBLER CHRISTOPHER A · CIK 0001229877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,626 shares

Expires 2027-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:20 UTC SaleCommon Stock 3,626 $397.94 $1,442,930.44
Disclosure

SEC source: 0001000697-26-000127 · form4.xml · nonDerivative · entry 2

KUEBLER CHRISTOPHER A · CIK 0001229877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,808

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:20 UTC Exercise / conversionCommon Stock 3,626 $136.43 $494,695.18
Disclosure

SEC source: 0001000697-26-000127 · form4.xml · nonDerivative · entry 1

KUEBLER CHRISTOPHER A · CIK 0001229877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,434

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:27 UTC GrantCommon Stock 63.03 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000119 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,280.54

F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2027, pursuant to an election previously made by the Reporting Person.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 20:24 UTC
Jiang WeiDirector
GrantCommon Stock 67.42 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000117 · form4.xml · nonDerivative · entry 1

Jiang Wei · CIK 0001867980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,572.75

F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors.

Read SEC document
June 24, 2026 Filed Jun 25, 2026 21:25 UTC
Carpio Robert L IIISVP Waters Analytical Sciences
Tax withholdingCommon Stock 189 $369.18 $69,775.02
Disclosure

SEC source: 0001000697-26-000115 · form4.xml · nonDerivative · entry 1

Carpio Robert L III · CIK 0002027463 · SVP Waters Analytical Sciences

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,426

F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:55 UTC
Chaubal AmolSVP & Chief Financial Officer
Tax withholdingCommon Stock 239 $352.21 $84,178.19
Disclosure

SEC source: 0001000697-26-000113 · form4.xml · nonDerivative · entry 1

Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,622.8449

F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.

F2 · balance_after: Includes 65.4519 shares of common stock acquired on March 31, 2026, pursuant to the Waters Corporation Amended and Restated 2009 Employee Stock Purchase Plan, in a transaction that was exempt pursuant to Rule 16b-3(c).

Read SEC document
April 06, 2026 Filed Apr 7, 2026 20:36 UTC
Bennett JianqingSVP Waters Adv. Diagnostics
Tax withholdingCommon Stock 302 $304.09 $91,835.18
Disclosure

SEC source: 0001000697-26-000111 · form4.xml · nonDerivative · entry 1

Bennett Jianqing · CIK 0001856691 · SVP Waters Adv. Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,532

F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 21:03 UTC
Jiang WeiDirector
GrantCommon Stock 64.06 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000109 · form4.xml · nonDerivative · entry 1

Jiang Wei · CIK 0001867980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,505.33

F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2036, pursuant to an election previously made by the Reporting Person.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 21:00 UTC GrantCommon Stock 68.44 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000107 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,217.51

F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2027, pursuant to an election previously made by the Reporting Person.

Read SEC document
March 16, 2026 Filed Mar 18, 2026 20:37 UTC
Jiang WeiDirector
PurchaseCommon Stock 500 $289.46 $144,730.00
Disclosure

SEC source: 0001000697-26-000105 · form4.xml · nonDerivative · entry 1

Jiang Wei · CIK 0001867980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,441.27

Read SEC document
March 06, 2026 Filed Mar 10, 2026 20:21 UTC PurchaseCommon Stock 1,000 $306.34 $306,340.00
Disclosure

SEC source: 0001000697-26-000103 · form4.xml · nonDerivative · entry 1

FEARON RICHARD H · CIK 0001188586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,302

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $305.84 to $306.49 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:24 UTC
Batra UditDirector · President and CEO
Tax withholdingCommon Stock 3,417 $307.23 $1,049,804.91
Disclosure

SEC source: 0001000697-26-000101 · form4.xml · nonDerivative · entry 1

Batra Udit · CIK 0001821498 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,140

F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported performance stock units.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:22 UTC
Chaubal AmolSVP & Chief Financial Officer
Tax withholdingCommon Stock 709 $307.23 $217,826.07
Disclosure

SEC source: 0001000697-26-000099 · form4.xml · nonDerivative · entry 1

Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,796.393

F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported performance stock units.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:19 UTC
Bennett JianqingSVP Waters Adv. Diagnostics
Tax withholdingCommon Stock 410 $307.23 $125,964.30
Disclosure

SEC source: 0001000697-26-000097 · form4.xml · nonDerivative · entry 1

Bennett Jianqing · CIK 0001856691 · SVP Waters Adv. Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,834

F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported performance stock units.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:33 UTC
Carpio Robert L IIISVP Waters Analytical Sciences
GrantStock Option (Right to Buy) · Derivative 4,884 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000095 · form4.xml · derivative · entry 2

Carpio Robert L III · CIK 0002027463 · SVP Waters Analytical Sciences

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,884

Underlying: Common Stock · 4,884 shares

Expires 2036-02-25

F2 · derivative.exercise_date: The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:33 UTC
Carpio Robert L IIISVP Waters Analytical Sciences
GrantCommon Stock 997 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000095 · form4.xml · nonDerivative · entry 1

Carpio Robert L III · CIK 0002027463 · SVP Waters Analytical Sciences

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,615

F1 · shares: Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:32 UTC
Bennett JianqingSVP Waters Adv. Diagnostics
GrantStock Option (Right to Buy) · Derivative 4,826 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000093 · form4.xml · derivative · entry 2

Bennett Jianqing · CIK 0001856691 · SVP Waters Adv. Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,826

Underlying: Common Stock · 4,826 shares

Expires 2036-02-25

F2 · derivative.exercise_date: The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:32 UTC
Bennett JianqingSVP Waters Adv. Diagnostics
GrantCommon Stock 986 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000093 · form4.xml · nonDerivative · entry 1

Bennett Jianqing · CIK 0001856691 · SVP Waters Adv. Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,244

F1 · shares: Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:31 UTC
Chaubal AmolSVP & Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 7,125 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000091 · form4.xml · derivative · entry 2

Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,125

Underlying: Common Stock · 7,125 shares

Expires 2036-02-25

F2 · derivative.exercise_date: The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:31 UTC
Chaubal AmolSVP & Chief Financial Officer
GrantCommon Stock 1,455 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000091 · form4.xml · nonDerivative · entry 1

Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,505.393

F1 · shares: Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:29 UTC
Batra UditDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 25,283 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000089 · form4.xml · derivative · entry 2

Batra Udit · CIK 0001821498 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,283

Underlying: Common Stock · 25,283 shares

Expires 2036-02-25

F2 · derivative.exercise_date: The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:29 UTC
Batra UditDirector · President and CEO
GrantCommon Stock 5,165 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000089 · form4.xml · nonDerivative · entry 1

Batra Udit · CIK 0001821498 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,557

F1 · shares: Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:23 UTC GrantStock Option (Right to Buy) · Derivative 57 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000085 · form4.xml · derivative · entry 2

KUEBLER CHRISTOPHER A · CIK 0001229877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57

Underlying: Common Stock · 57 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:23 UTC GrantCommon Stock 23 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000085 · form4.xml · nonDerivative · entry 1

KUEBLER CHRISTOPHER A · CIK 0001229877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,808

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:25 UTC GrantStock Option (Right to Buy) · Derivative 57 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000087 · form4.xml · derivative · entry 2

Vergnano Mark · CIK 0001474107 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57

Underlying: Common Stock · 57 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:25 UTC GrantCommon Stock 23 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000087 · form4.xml · nonDerivative · entry 1

Vergnano Mark · CIK 0001474107 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:22 UTC GrantStock Option (Right to Buy) · Derivative 57 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000083 · form4.xml · derivative · entry 2

Knight Heather · CIK 0001967528 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57

Underlying: Common Stock · 57 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:22 UTC GrantCommon Stock 23 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000083 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,149.07

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:21 UTC
Jiang WeiDirector
GrantStock Option (Right to Buy) · Derivative 57 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000081 · form4.xml · derivative · entry 2

Jiang Wei · CIK 0001867980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57

Underlying: Common Stock · 57 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:21 UTC
Jiang WeiDirector
GrantCommon Stock 23 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000081 · form4.xml · nonDerivative · entry 1

Jiang Wei · CIK 0001867980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,941.27

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:19 UTC GrantStock Option (Right to Buy) · Derivative 57 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000079 · form4.xml · derivative · entry 2

Huang Pearl S · CIK 0001837486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57

Underlying: Common Stock · 57 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:19 UTC GrantCommon Stock 23 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000079 · form4.xml · nonDerivative · entry 1

Huang Pearl S · CIK 0001837486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,276.3

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:18 UTC GrantStock Option (Right to Buy) · Derivative 877 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000077 · form4.xml · derivative · entry 2

Fraser Claire · CIK 0001382031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 877

Underlying: Common Stock · 877 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:18 UTC GrantCommon Stock 358 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000077 · form4.xml · nonDerivative · entry 1

Fraser Claire · CIK 0001382031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 489

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:16 UTC GrantStock Option (Right to Buy) · Derivative 57 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000075 · form4.xml · derivative · entry 2

FEARON RICHARD H · CIK 0001188586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57

Underlying: Common Stock · 57 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:16 UTC GrantCommon Stock 23 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000075 · form4.xml · nonDerivative · entry 1

FEARON RICHARD H · CIK 0001188586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,302

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:13 UTC GrantStock Option (Right to Buy) · Derivative 57 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000073 · form4.xml · derivative · entry 2

Brennan Daniel J. · CIK 0001595612 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57

Underlying: Common Stock · 57 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:13 UTC GrantCommon Stock 23 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000073 · form4.xml · nonDerivative · entry 1

Brennan Daniel J. · CIK 0001595612 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,355

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:12 UTC GrantStock Option (Right to Buy) · Derivative 57 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000071 · form4.xml · derivative · entry 2

BADDOUR LINDA · CIK 0001181151 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57

Underlying: Common Stock · 57 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:12 UTC GrantCommon Stock 23 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000071 · form4.xml · nonDerivative · entry 1

BADDOUR LINDA · CIK 0001181151 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,899

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:09 UTC GrantStock Option (Right to Buy) · Derivative 57 $0.00 Strike: $319.44 $0.00
Disclosure

SEC source: 0001000697-26-000069 · form4.xml · derivative · entry 2

Ornskov Flemming · CIK 0001709473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57

Underlying: Common Stock · 57 shares

Expires 2036-02-25

F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.

Read SEC document
February 25, 2026 Filed Feb 28, 2026 00:09 UTC GrantCommon Stock 336 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000069 · form4.xml · nonDerivative · entry 1

Ornskov Flemming · CIK 0001709473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,271

F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.

Read SEC document
February 05, 2026 Filed Feb 7, 2026 00:34 UTC
Carpio Robert L IIISVP, Waters Division
Tax withholdingCommon Stock 38 $376.89 $14,321.82
Disclosure

SEC source: 0001000697-26-000048 · form4.xml · nonDerivative · entry 1

Carpio Robert L III · CIK 0002027463 · SVP, Waters Division

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,618

F1 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.

Read SEC document
February 05, 2026 Filed Feb 7, 2026 00:33 UTC
Bennett JianqingSVP TA Instruments Division
Tax withholdingCommon Stock 43 $376.89 $16,206.27
Disclosure

SEC source: 0001000697-26-000046 · form4.xml · nonDerivative · entry 2

Bennett Jianqing · CIK 0001856691 · SVP TA Instruments Division

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,258

F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.

Read SEC document
February 05, 2026 Filed Feb 7, 2026 00:32 UTC
Chaubal AmolSVP & Chief Financial Officer
Tax withholdingCommon Stock 58 $376.89 $21,859.62
Disclosure

SEC source: 0001000697-26-000044 · form4.xml · nonDerivative · entry 2

Chaubal Amol · CIK 0001773089 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,050.393

F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.

Read SEC document
February 05, 2026 Filed Feb 7, 2026 00:29 UTC
Batra UditDirector · President and CEO
Tax withholdingCommon Stock 218 $376.89 $82,162.02
Disclosure

SEC source: 0001000697-26-000042 · form4.xml · nonDerivative · entry 2

Batra Udit · CIK 0001821498 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,392

F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units.

Read SEC document
February 04, 2026 Filed Feb 7, 2026 00:33 UTC
Bennett JianqingSVP TA Instruments Division
GrantCommon Stock 1,385 $0.00 $0.00
Disclosure

SEC source: 0001000697-26-000046 · form4.xml · nonDerivative · entry 1

Bennett Jianqing · CIK 0001856691 · SVP TA Instruments Division

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,301

F1 · shares: Represents performance-based restricted stock units ("PSUs") originally granted on February 8, 2023, subject to pre-determined service and performance-based vesting requirements. The level of achievement of the performance-based vesting requirement for the PSUs was certified by the Issuer's Compensation Committee on February 4, 2026, and the PSUs will vest in full upon satisfaction of the service-based vesting requirement on March 1, 2026. The PSUs are convertible into shares of the Issuer's Common Stock on a one-to-one basis upon vesting and settlement.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.